Literature DB >> 20811986

Structural studies of MAP Kinase cascade components.

Elizabeth J Goldsmith1, Xiaoshan Min, Haixia He, Tianjun Zhou.   

Abstract

MAPK cascade components have been the subject of structural analysis, advancing our understanding of how these enzymes are activated and how they interact. A surprising finding has been that unique inactive conformers are adopted by many of these kinases. These inactive conformers are interesting and often require experimental phases to determine their crystal structures because molecular replacement techniques are not successful. Here, we describe the preparation of MAP2K MEK6 and MAP3K TAO2 substituted with selenomethionine (SeMet) for de novo phasing. TAO2 and SeMet TAO2 were expressed in insect cells.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20811986     DOI: 10.1007/978-1-60761-795-2_13

Source DB:  PubMed          Journal:  Methods Mol Biol        ISSN: 1064-3745


  4 in total

1.  Hyperthermia enhances the sensitivity of pancreatic cancer SW1990 cells to gemcitabine through ROS/JNK signaling.

Authors:  Hangbin Jin; Yanyan Zhao; Jianfeng Yang; Xiaofeng Zhang; Shenglin Ma
Journal:  Oncol Lett       Date:  2018-09-18       Impact factor: 2.967

2.  Precisely ordered phosphorylation reactions in the p38 mitogen-activated protein (MAP) kinase cascade.

Authors:  John M Humphreys; Alexander T Piala; Radha Akella; Haixia He; Elizabeth J Goldsmith
Journal:  J Biol Chem       Date:  2013-06-06       Impact factor: 5.157

3.  Quantitative CEST and MT at 1.5T for monitoring treatment response in glioblastoma: early and late tumor progression during chemoradiation.

Authors:  Rachel W Chan; Hanbo Chen; Sten Myrehaug; Eshetu G Atenafu; Greg J Stanisz; James Stewart; Pejman Jabehdar Maralani; Aimee K M Chan; Shadi Daghighi; Mark Ruschin; Sunit Das; James Perry; Gregory J Czarnota; Arjun Sahgal; Angus Z Lau
Journal:  J Neurooncol       Date:  2020-11-16       Impact factor: 4.130

Review 4.  MLK3 Signaling in Cancer Invasion.

Authors:  Chotirat Rattanasinchai; Kathleen A Gallo
Journal:  Cancers (Basel)       Date:  2016-05-19       Impact factor: 6.639

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.